Company Valuation: IntegraGen

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020
Market Cap 1 6.536 13.61
Change - 108.2%
Enterprise Value (EV) 1 4.017 10.5
Change - 161.33%
P/E -23x -36.6x
PBR 2.61x 6.28x
PEG - -1.3x
Capitalization / Revenue 0.79x 1.51x
EV / Revenue 0.49x 1.17x
EV / EBITDA -37.6x -375x
EV / EBIT -11.1x -41.2x
EV / FCF - -
FCF Yield - -
Dividend per Share 2 - -
Rate of return - -
EPS 2 -0.0439 -0.0559
Distribution rate - -
Net sales 1 8.28 9
EBITDA 1 -0.107 -0.028
EBIT 1 -0.3631 -0.255
Net income 1 -0.2848 -0.375
Net Debt 1 -2.519 -3.109
Reference price 2 1.0100 2.0500
Nbr of stocks (in thousands) 6,471 6,638
Announcement Date 3/4/20 11/6/21
1EUR in Million2EUR
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 551K
17.43x6.68x12.81x1.71% 66.7B
30.07x8.27x26.77x0.07% 56.88B
38.45x6.84x20.45x0.85% 56.53B
46.55x6.14x30.16x-.--% 46.49B
35.48x3.35x14.48x-.--% 44.8B
-22.71x62.58x-21.48x-.--% 41.59B
35.87x8.84x23.03x0.37% 35.35B
41.46x8.08x26.8x-.--% 33.29B
-69.81x13.21x-71.01x-.--% 25.1B
Average 16.98x 13.78x 6.89x 0.33% 41B
Weighted average by Cap. 21.52x 12.92x 11.34x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - IntegraGen

Historical PBR trend

Valuation ratios - PBR - IntegraGen

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - IntegraGen

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - IntegraGen